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ABSTRACT 
    Objective: Uvulopalatopharyngoplasty (UPPP) is the most common surgical 
procedure performed to treat obstructive sleep apnea (OSA).  This surgery, when 
performed alone, benefits only a minority of patients.  This study was undertaken to 
determine the efficacy of oral appliance (OA) therapy following unsuccessful UPPP and 
assess for specific patient and polysomnographic characteristics that may identify those 
patients most likely to benefit from this combined treatment strategy. 
    Study Design: Retrospective of clinical outcomes in patients undergoing UPPP 
followed by treatment with an OA. 
    Methods: Polysomnographic results (baseline, status post UPPP, and status post 
UPPP with oral appliance use), age, gender, race and body mass index were subjected 
to statistical analysis. 
     Results: The mean AHI decreased from 23.6 at baseline to 8.6 following UPPP and 
oral appliance therapy. The mean O2 nadir increased from 83% at baseline to 89.9% 
following UPPP and treatment with an oral appliance. Fifty percent of patients (9/18) 
achieved an AHI <5 and were deemed “cured” of their disease. Seventy-three percent 
of patients (13/18) achieved benefit with an AHI <20 and ≥50% reduction in their 
baseline AHI, deemed “successful therapy”.  No statistically relevant demographic or 
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polysomnographic differences were found between those who were “cured” and those 
with persistent disease with the exception that the O2 nadir status post UPPP was 
found to be lower in the “cured” group.  
    Conclusion: Oral appliance therapy is an effective treatment option for the majority 
of patients who have persistent obstructive sleep apnea following unsuccessful UPPP.  
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INTRODUCTION 
Obstructive sleep apnea (OSA) is a common disorder, with an estimated 
prevalence of approximately 4% in men and 2% in women and may be much higher in 
middle aged men, postmenopausal women and the elderly1. Untreated OSA is 
associated with excessive daytime sleepiness, decreased quality of life, cognitive 
impairment, cardiovascular sequelae and increased mortality.  Continuous positive 
airway pressure (CPAP) is the gold standard treatment for OSA as it is the most likely 
treatment to yield an AHI < 5 when used on a nightly basis.  However, acceptance and 
adherence to CPAP treatment pose major clinical challenges for many patients. Poor 
compliance with CPAP may decrease the effectiveness of this treatment and other non-
CPAP modalities may result in a lower effective AHI when taking into account actual 
patterns of CPAP use.2 Other treatment options for OSA include surgical therapy and 
use of an oral appliance. Although use of an oral appliance can be highly effective, it is 
still considered to be a compliance based therapy requiring a change in patient behavior 
and many patients opt for surgical treatment instead. 
Despite increasing evidence that the majority of patients with OSA have 
multilevel obstruction, uvulopalatopharyngoplasty (UPPP) remains the most common 
surgical procedure performed to treat OSA with an overall success rate of 
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approximately 40% in unselected patients3. Oral appliance (OA) therapy has become an 
increasingly common non-surgical treatment for CPAP intolerant patients, but it has 
rarely been evaluated in patients with persistent OSA following unsuccessful UPPP.  
This study was undertaken to determine the efficacy of OA following unsuccessful 
UPPP and attempt to define specific polysomnographic (PSG) and patient 
characteristics that may help identify those individuals most likely to benefit from use of 




The medical records of patients having persistent OSA following UPPP and were 
subsequently treated with an OA were retrospectively reviewed. OSA was defined as an 
overall apnea hypopnea index (AHI) of 5 or more events per hour.4   Patients were 
eligible for inclusion if they had polysomnographic data at baseline, status post UPPP, 
and status post UPPP with use of an OA.  Postoperative PSG was usually obtained 
between 4 and 6 months following surgery. PSG following oral appliance therapy was 
obtained once final adjustments were made by the supervising dentist. Patients were 
excluded if PSG data from any of the three time periods was unavailable. All study 
patients attended a multidisciplinary Alternatives to CPAP Clinic at the University of 
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Michigan between December 1997 and October 2015.  The Alternatives to CPAP Clinic 
in which the patients were treated was established to serve those intolerant of CPAP 
who were highly motivated to seek non-CPAP therapy. This Clinic included evaluations 
by a sleep medicine physician, otolaryngology-head and neck surgeon, oral 
maxillofacial surgeon and dentist board certified by the American Board of Dental Sleep 
Medicine (as of 2004). All patients in this study received their oral appliance from the 
same dentist via this clinic, whereas UPPP was performed by more than one 
otolaryngologist. This study was approved by the University of Michigan Institutional 
Review Board (HUM 00108735). 
Demographic information including age, gender, race, and body mass index 
(BMI) was obtained.  Outcomes following UPPP and OA therapy were classified as 
either: “cured”, defined as an AHI<5 or as “successful therapy”, defined as an AHI<20 
and a ≥50% reduction in the pretreatment AHI in order to compare the current study’s 
results to historical Otolaryngologic surgery reports utilizing this definition.5 The term 
“cured” is used to describe resolution of obstructive events with use of OA therapy. 
The oral appliance used for patients included in this study was a Thornton 
Adjustable Positioner at the discretion of the dental provider.  Contraindications to OA 
use included less than nine teeth in each of the upper and lower jaws; discomfort 
protruding the lower jaw forward greater than 5 mm; discomfort in opening the jaw less 
than 33 millimeters; evidence of temporomandibular joint abnormality or chronic joint 
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pain; occlusal wear (>20%) of the clinical crown indicative of severe bruxism; and 
significant periodontal disease defined as greater than 50% bone loss around the teeth 
and/or tooth mobility. 
Statistical analyses were carried out using SPSS version 24.0 for Windows (IBM 
Corp.).  Characteristics of patients deemed “cured” and those with “successful therapy” 
were compared to patients with persistent OSA.  One-way analysis of variance 
(ANOVA) was conducted for repeated measures in order to analyze the change in PSG 
parameters. Unpaired t-tests were used to compare continuous variables (age, BMI, 
AHI, and SpO2 measures) and Chi-square was used to compare dichotomous data 
(gender and race) between groups. Logistic regression was performed to predict 
“successful therapy” and “cure” as previously defined. 
 
RESULTS 
Between December 1997 and October 2015, 1739 patients were evaluated in the 
Alternatives to CPAP Clinic. Of these, 417 underwent surgery inclusive of UPPP. Two 
hundred and fifty-one patients underwent UPPP only. Surgical “success”, as previously 
defined, was achieved in 151 (60%) of these patients.  
Three hundred patients were referred for oral appliance therapy. Twenty-two of 
those patients had undergone previous UPPP. Eighteen patients following unsuccessful 
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UPPP and subsequently treated with an OA with complete polysomnographic results 
were identified for study. The majority were male and Caucasian. Demographics are 
shown in Table 1.  
The mean AHI decreased from 23.6 at baseline to 21.4 following UPPP. The 
mean AHI further decreased from 21.4 to 8.6 following oral appliance therapy (Figure 
1). The mean O2 nadir increased from 83.0% at baseline to 84.9% following UPPP and 
further increased to 89.9% following oral appliance therapy. 
Seventy-three percent of patients (13/18) achieved benefit with an AHI <20 and 
≥50% reduction in their baseline AHI.  Fifty percent of patients (9/18) achieved an AHI 
<5 and were deemed “cured” of their disease. No statistically relevant demographic 
differences existed between those who had persistent disease compared to those who 
were either “successfully” treated or “cured” (Tables 2 and 3). 
The baseline AHI was higher in those who achieved an AHI <20 and ≥50% 
reduction in AHI, but this difference was not found to reach statistical significance.  In a 
logistic regression, after accounting age, gender, race, body mass index (BMI) and 
post-UPPP O2 nadir, the baseline AHI did not predict a successful outcome with the 
use of an oral appliance.  In addition, the AHI and O2 nadir following UPPP, taking into 
account age, gender, race, BMI did not predict “successful therapy” with an oral 
appliance 
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For those patients who were deemed “cured” vs. those who were not, the post-
UPPP O2 nadir was found to be significantly lower. No other polysomnographic 
parameters or patient characteristics were found to be significantly different between the 
two groups (Table 3). 
 
DISCUSSION 
In this study, nearly three quarters of patients benefited from the use of an oral 
appliance following unsuccessful UPPP and half were cured of their disease. Although 
the sample size was small, the present series is the largest report to date on the 
effectiveness of OA use following UPPP.  Millman and colleagues in 1998 published the 
only other study on the use of OA following unsuccessful UPPP in which similar results 
to the current study were described with an overall response rate (AHI<20 and a ≥50% 
reduction in AHI) of 66%.6 
Historically, surgical treatment for OSA focused on single site surgery of the 
oropharynx. The UPPP procedure, with or without tonsillectomy, has been the mainstay 
of surgical therapy following its introduction in the early 1980’s. UPPP was designed to 
alleviate retropalatal collapse in patients with OSA, and has been modified to include 
the uvulopalatal flap, Z-palatopharyngoplasty and expansion sphincter pharyngoplasty 
in an attempt to improve success rates and prevent post-operative complications.7  In 
addition, better patient selection utilizing the Friedman stagingsystem has led to 
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improved patient selection and success rates 8. However, despite these improvements, 
isolated palatal surgery fails to address a potential retroglossal site of obstruction 
present in many patients with OSA. 9,10,11  
Data from the 2006 Nationwide Inpatient Sample, State Ambulatory Surgery 
Database and State Inpatient Database revealed that of the 35,263 outpatient and 
inpatient operations performed for the treatment of OSA, more than 75% were limited to 
isolated palatal procedures, and only 19% involved hypopharyngeal procedures (e.g. 
mandibulotomy with genioglossus muscle advancement, lingual tonsillectomy, hyoid 
suspension, etc.). 12 Failure to perform multilevel surgery may be attributable to lack of 
training in hypopharyngeal surgery.  A recent survey of 103 accredited Otolaryngology 
residency program directors in the United States revealed high rates of resident surgical 
competency in oropharyngeal procedures (100% for UPPP) and lesser competency in 
hypopharyngeal procedures.13 Practice patterns among practicing surgeons self-
identified as having a special interest in sleep medicine revealed that only 39% believed 
their residency training in OSA surgery was of high quality and greater than 40% 
reported receiving limited training in hypopharyngeal procedures, with the exception of 
radiofrequency tongue ablation.14   
During the past two decades, there has been increased awareness of multilevel 
obstruction in patients with OSA. In part, this was in response to the fact that non-
responders to isolated palatal surgery were frequently found to have additional sites of 
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obstruction, usually at the level of the hypopharynx. Fujita was the first to describe 
anatomic levels of obstruction in patients with OSA and subsequently created a formal 
classification system.15 The vast majority of patients were classified as having both 
oropharyngeal and hypopharyngeal sites of collapse. Other studies have similarly 
reported that the majority of patients with OSA have multilevel obstruction.5,9,10,11  
There are numerous reports documenting the beneficial outcome of multilevel 
surgery for OSA.  In one of the largest reported case series, Riley and colleagues 
reported an overall success rate of 61% in 306 consecutive patients undergoing phase I 
surgery (i.e. non-maxillomandibular advancement) inclusive of multilevel procedures. 
Success rates were higher in those with mild and moderate OSA, at 71% and 78%, 
respectively.10  A more recent meta-analysis of nearly 2,000 patients who underwent 
multilevel surgery reported an overall success rate of 66%, similar to that achieved in 
the current study combining UPPP and OA therapy.5  The option of OA following 
unsuccessful UPPP may be of greatest utility to surgeons capable of performing UPPP 
but without experience in additional hypopharyngeal procedures, but may also be 
important to more experienced sleep surgeons when considering further treatment 
following failed UPPP, especially for patients hesitant to undergo additional surgery. 
Treatment with an OA works by advancing and stabilizing the mandible and 
genioglossus muscle anteriorly thereby increasing the retroglossal airway. It also leads 
to an increase in the retroplatal area via mechanical coupling of the palatoglossus 
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muscle and intrinsic tongue musculature.16 Adherence rates for OA use are typically 
high and have been reported to be better than those with CPAP use.17 Side effects 
requiring discontinuation of OA use such as occlusal changes and temporomandibular 
joint inflammation can be minimized with close follow up by a qualified dentist. 
The 2015 clinical practice guidelines for the treatment of OSA with oral appliance 
therapy recommended that physicians consider prescription of an OA for adult patients 
who are intolerant of CPAP therapy or prefer an alternate therapy.18 This systematic 
review found that OAs significantly reduce the AHI and increase the oxygen saturation 
nadir across all levels of OSA severity. In addition, OA use was found to reduce daytime 
sleepiness and improve disease specific quality of life measures. As found in the current 
study, no specific patient characteristics, including age, gender, BMI and cephalometric 
measurements were identified in this meta-analysis to predict successful treatment.18 
Similar findings were observed in the current study with a decrease in AHI from 21.4 to 
8.6 and increase in oxygen saturation nadir from 84.9 to 89.9 with the use of an oral 
appliance following unsuccessful UPPP. Of course, it cannot be determined if similar 
results would have been achieved with the use of oral appliance alone, since this 
patient population decided to pursue surgical treatment (UPPP) of their OSA prior to 
additional treatment with OA. Despite well documented improvement in disease severity 
and high compliance rates with OA therapy, some patients still prefer surgical treatment 
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and its potential to be a single, discrete intervention as opposed to an alternative 
compliance based therapy like OA. 
Until recently, predicting the effectiveness of OA therapy prior to use was not 
feasible. However, in 2013, Remmers and colleagues examined the predictive potential 
of a remote controlled mandibular positioning device (MATRx, Zephyr Sleep 
Technologies Inc., Calgary, Alberta Canada).19 During a titration polysomnogram, a 
remotely controlled mandibular positioner was attached to disposable dental trays fitted 
to the patient’s dentition with impression material. Among the study’s 67 patients in this 
prospective, blinded outcome study, success with use of an OA (defined as AHI<10) 
was predicted in 32 subjects. Of the 32 patients who were predicted to benefit from OA 
use, 30 (94%) went on to achieve an AHI <10 with traditional OA use as confirmed by 
subsequent polysomnography.  Patients who were predicted to not benefit with OA 
treatment failed to reach an AHI<10 in 83% of cases with subsequent traditional OA 
use. The model’s sensitivity, specificity, positive predictive value, and negative 
predictive value were 86%, 92%, 94%, and 83% respectively. The use of an OA pre-
treatment titration study prior to prescribing OA therapy is currently available at only a 
sleep few centers around the country. It has only recently been implemented at the 
authors’ institution, and was not available to patients included in this study. 
Despite reviewing data collected over an 18-year period from a clinic specifically 
created to treat CPAP intolerant patients, limitations of the current study include its 
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relatively small sample size. This may be, in part, due to limited interest or willingness of 
individuals following unsuccessful UPPP to undergo further treatment without any 
further guarantee of success. This reticence may be compounded by the expense of an 
OA, which may be only partially covered by medical or dental insurance. Another 
limitation is that some otherwise qualified patients could not be included due to lack of 
PSG data prior to or following each intervention. Missing or incomplete information is an 
inherent problem with retrospective studies. In addition to limiting the sample size, it can 
lead to a no response bias in the results as subjects with missing information may 
systematically differ from the others. In addition, the majority of patients studied were 
male and Caucasian which limits the generalizability of the results. Finally, all study 
patients were selected from a group of highly motivated patients attending a 
multidisciplinary Alternatives to CPAP Clinic for patients intolerant of CPAP therapy, and 
as such may not be representative of the larger population of CPAP intolerant patients. 
Nonetheless, despite these limitations, this report describes the largest cohort of 
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Gender    83% Male (n15) 
Race     78% Caucasian (n14) 
Mean Age (years)   47.0 +/- 11.7 (range 22.5-71.8)   
BMI (kg/m2)    30.4 +/- 4.2 (range 22.8-30.4) 
Baseline AHI    23.6 +/- 17.4 (range 7.7-80.0) 
Baseline O2 Nadir   83.3% +/- 6.1 (range 70.0-91.0) 
Post-UP3 AHI   21.4 +/- 14.3 (range 3.3-61.6) 
Post-UP3 O2 Nadir   84.9% +/- 8.1 (range 60-96) 
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Demographic Data of OSA Participants Subjected to UPPP followed by OA Therapy 
 



































































Ɨ “Successful therapy” defined as AHI <20 and ≥50% reduction from baseline AHI. 
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Demographic Data of OSA Participants Subjected to UPPP followed by OA Therapy 
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